Related Experiment Video
Updated: Dec 19, 2025
07:01
Experimental Paradigm for Measuring the Effects of Self-distancing in Young Children
Published on: March 1, 2019
8.3K
Understanding the age divide in COVID-19: why are children overwhelmingly spared?
K Lingappan1, H Karmouty-Quintana2, J Davies1
1Division of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Summary
Children experience milder COVID-19 due to lower viral entry factors and distinct immune responses. Understanding these differences in the developing lung may reveal new therapeutic targets for adults.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Respiratory Medicine
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, predominantly affecting adults with high mortality.
- Children generally exhibit milder symptoms, suggesting age-related protective mechanisms against severe disease progression.
Purpose of the Study:
- To investigate the age-based pathophysiological differences in COVID-19.
- To identify potential therapeutic targets by understanding why children are relatively spared from severe lung injury.
Main Methods:
- Comparative analysis of clinical courses in children and adults.
- Examination of molecular mechanisms, including viral entry mediators (ACE2, TMPRSS2) and immune responses (T cells, cytokines, neutrophils).
- Consideration of lung repair capacity in pediatric populations.
Main Results:
- Children show decreased expression of angiotensin-converting enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2), hindering viral entry.
- Pediatric immune responses feature more CD4+ T cells, less neutrophil infiltration, reduced pro-inflammatory cytokines, and increased immunomodulatory cytokines.
- The developing lung in children may possess enhanced recovery and repair capabilities post-infection.
Conclusions:
- Age-related differences in viral entry factors and immune profiles contribute to milder COVID-19 in children.
- Understanding these protective mechanisms in the pediatric population can inform therapeutic strategies for adult COVID-19 patients.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
147
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
189
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
189
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
123
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
123
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
164
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
164
01:29Drug Dosing: Infants and Children
171
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
171
01:26Factors Affecting the Risk of Infection
13.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K